Also, in the context of multiple sclerosis, relapsing patients exhibited overexpression of BMP-2,4,5 but not BMP-7 (Mausner-Fainberg et al. 2013), again suggesting a relative unavailability of BMP-7 in poorer autoimmune disease outcome. This evidence concerns the gene BMP7 and multiple sclerosis.